Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 4
1999 2
2000 5
2001 6
2002 2
2003 2
2004 2
2005 4
2006 3
2007 8
2008 4
2009 2
2010 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.
Kumar S. Kumar S. Expert Opin Drug Metab Toxicol. 2010 Feb;6(2):115-31. doi: 10.1517/17425250903431040. Expert Opin Drug Metab Toxicol. 2010. PMID: 20064075 Free PMC article. Review.
Thermodynamics of ligand binding to P450 2B4 and P450eryF studied by isothermal titration calorimetry.
Muralidhara BK, Halpert JR. Muralidhara BK, et al. Drug Metab Rev. 2007;39(2-3):539-56. doi: 10.1080/03602530701498182. Drug Metab Rev. 2007. PMID: 17786637 Review.
Use of directed evolution of mammalian cytochromes P450 for investigating the molecular basis of enzyme function and generating novel biocatalysts.
Kumar S, Halpert JR. Kumar S, et al. Biochem Biophys Res Commun. 2005 Dec 9;338(1):456-64. doi: 10.1016/j.bbrc.2005.08.080. Epub 2005 Aug 22. Biochem Biophys Res Commun. 2005. PMID: 16126165 Review.
Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism.
Halpert JR, Domanski TL, Adali O, Biagini CP, Cosme J, Dierks EA, Johnson EF, Jones JP, Ortiz de Montellano P, Philpot RM, Sibbesen O, Wyatt WK, Zheng Z. Halpert JR, et al. Drug Metab Dispos. 1998 Dec;26(12):1223-31. Drug Metab Dispos. 1998. PMID: 9860932 Review.
Molecular basis of P450 inhibition and activation: implications for drug development and drug therapy.
Szklarz GD, Halpert JR. Szklarz GD, et al. Drug Metab Dispos. 1998 Dec;26(12):1179-84. Drug Metab Dispos. 1998. PMID: 9860924 Review.
Use of homology modeling in conjunction with site-directed mutagenesis for analysis of structure-function relationships of mammalian cytochromes P450.
Szklarz GD, Halpert JR. Szklarz GD, et al. Life Sci. 1997;61(26):2507-20. doi: 10.1016/s0024-3205(97)00717-0. Life Sci. 1997. PMID: 9416773 Review.
Allosteric P450 mechanisms: multiple binding sites, multiple conformers or both?
Davydov DR, Halpert JR. Davydov DR, et al. Expert Opin Drug Metab Toxicol. 2008 Dec;4(12):1523-35. doi: 10.1517/17425250802500028. Expert Opin Drug Metab Toxicol. 2008. PMID: 19040328 Free PMC article. Review.
The genetic determinants of the CYP3A5 polymorphism.
Hustert E, Haberl M, Burk O, Wolbold R, He YQ, Klein K, Nuessler AC, Neuhaus P, Klattig J, Eiselt R, Koch I, Zibat A, Brockmöller J, Halpert JR, Zanger UM, Wojnowski L. Hustert E, et al. Pharmacogenetics. 2001 Dec;11(9):773-9. doi: 10.1097/00008571-200112000-00005. Pharmacogenetics. 2001. PMID: 11740341
Electron transfer in the complex of membrane-bound human cytochrome P450 3A4 with the flavin domain of P450BM-3: the effect of oligomerization of the heme protein and intermittent modulation of the spin equilibrium.
Davydov DR, Sineva EV, Sistla S, Davydova NY, Frank DJ, Sligar SG, Halpert JR. Davydov DR, et al. Biochim Biophys Acta. 2010 Mar;1797(3):378-90. doi: 10.1016/j.bbabio.2009.12.008. Epub 2009 Dec 21. Biochim Biophys Acta. 2010. PMID: 20026040 Free PMC article.
Identification and functional characterization of eight CYP3A4 protein variants.
Eiselt R, Domanski TL, Zibat A, Mueller R, Presecan-Siedel E, Hustert E, Zanger UM, Brockmoller J, Klenk HP, Meyer UA, Khan KK, He YA, Halpert JR, Wojnowski L. Eiselt R, et al. Pharmacogenetics. 2001 Jul;11(5):447-58. doi: 10.1097/00008571-200107000-00008. Pharmacogenetics. 2001. PMID: 11470997
47 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback